Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Corrigendum to "Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis" [Mol. Cell Endocrinol.] 399 (2015) 235-243

Research output: Other contributionResearch

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@misc{90b149b8256542e4a206a6c3c29962c4,
title = "Corrigendum to {"}Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis{"} [Mol. Cell Endocrinol.] 399 (2015) 235-243",
author = "Winge, {S B} and J Nielsen and A Jorgensen and S Owczarek and Ewen, {K A} and Nielsen, {J E} and A Juul and V Berezin and {Rajpert-De Meyts}, E",
year = "2018",
month = "1",
day = "15",
doi = "10.1016/j.mce.2017.12.001",
language = "English",
volume = "460",
type = "Other",

}

RIS

TY - GEN

T1 - Corrigendum to "Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis" [Mol. Cell Endocrinol.] 399 (2015) 235-243

AU - Winge, S B

AU - Nielsen, J

AU - Jorgensen, A

AU - Owczarek, S

AU - Ewen, K A

AU - Nielsen, J E

AU - Juul, A

AU - Berezin, V

AU - Rajpert-De Meyts, E

PY - 2018/1/15

Y1 - 2018/1/15

U2 - 10.1016/j.mce.2017.12.001

DO - 10.1016/j.mce.2017.12.001

M3 - Other contribution

VL - 460

ER -

ID: 56715318